LASSBio-1425, an analog of thalidomide, decreases triglyceride and increases HDL cholesterol levels by inhibition of TNF-α production

LASSBio-1425, an analog of thalidomide, decreases triglyceride and increases HDL cholesterol levels by inhibition of TNF-α production

Saved in:
Bibliographic Details
Published in:International journal of cardiology Vol. 202; pp. 497 - 499
Main Authors: Fumian, Milla Machado, da Motta, Nadia Alice Vieira, Maia, Rodolfo, Fraga, Carlos Alberto Manssour, Barreiro, Eliezer Jesus, Ferreira de Brito, Fernanda Carla
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ireland Ltd 01-01-2016
Subjects:
Animals
Anti-inflammatory agents
Antiplatelet drugs
Atherosclerosis
Cardiovascular
Cholesterol, HDL - antagonists & inhibitors
Cholesterol, HDL - blood
Dose-Response Relationship, Drug
Hypercholesterolemia - blood
Hypercholesterolemia - drug therapy
Hypercholesterolemic diet
Lipid-lowering drugs
Male
Phthalimide derivative
Rats
Rats, Wistar
Thalidomide - analogs & derivatives
Thalidomide - pharmacology
Thalidomide - therapeutic use
Triglycerides - antagonists & inhibitors
Triglycerides - blood
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Tumor Necrosis Factor-alpha - blood
Lipid-lowering drugs
Antiplatelet drugs
Phthalimide derivative
Hypercholesterolemic diet
Anti-inflammatory agents
Atherosclerosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2015.09.071